Faeth Therapeutics Inc (FTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Operating Expenses | 9,784 | 7,969 | 5,077 | 5,364 | 4,907 |
| Operating Income | -9,784 | -7,969 | -5,077 | -5,364 | -4,907 |
| Interest Expense | 147 | 3 | 54 | 3 | 3 |
| Other Income | 160 | 0 | 0 | 0 | 0 |
| Pre-tax Income | -9,771 | -7,972 | -5,131 | -5,367 | -4,910 |
| Net Income Continuous | -9,771 | -7,972 | -5,131 | -5,367 | -4,910 |
| Net Income | $-9,771 | $-7,972 | $-5,131 | $-5,367 | $-4,910 |
| EPS Basic Total Ops | -6.40 | -8.40 | -50.20 | -60.00 | -60.40 |
| EPS Basic Continuous Ops | -6.39 | -8.43 | -50.68 | -60.07 | -60.43 |
| EPS Diluted Total Ops | -6.40 | -8.40 | -50.20 | -60.00 | -60.40 |
| EPS Diluted Continuous Ops | -6.39 | -8.43 | -50.68 | -60.07 | -60.43 |
| EBITDA(a) | $-9,662 | $-7,871 | $-5,007 | $-5,300 | $-4,855 |